Veer Bhavnagri - 17 Jan 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
General Counsel
Signature
/s/Veer Bhavnagri
Issuer symbol
ALLO
Transactions as of
17 Jan 2023
Net transactions value
-$21,120
Form type
4
Filing time
18 Jan 2023, 17:10:27 UTC
Previous filing
19 Dec 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale $21,120 -3,000 -0.51% $7.04 580,677 17 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.